Actively Recruiting

Phase 4
Age: 22Years - 75Years
All Genders
Healthy Volunteers
NCT04549935

The PRIME Study: A Randomized, Controlled, Prospective Study

Led by Vance Thompson Vision - MT · Updated on 2020-09-16

20

Participants Needed

1

Research Sites

49 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

To investigate the outcomes of patients undergoing bilateral RLE surgery with treatment of dexamethasone intracanilicular insert compared to topical standard care steroid. Desiged to look at patient preference comparing the insert to drops and will also look at patient outcomes including inflammatin and risk of cystoid macular edema post-operatively.

CONDITIONS

Official Title

The PRIME Study: A Randomized, Controlled, Prospective Study

Who Can Participate

Age: 22Years - 75Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Any adult patient who is planned to undergo bilateral RLE surgery with BCVA 20/30 or better
  • Willing and able to comply with clinic visits and study related procedures
  • Willing and able to sign the informed consent form
Not Eligible

You will not qualify if you...

  • Patients under the age of 22 or above the age of 75
  • Patients who are pregnant (must be ruled out in women of child-bearing age with pregnancy test)
  • Patients with active infectious ocular or extraocular disease
  • Patients actively treated with local or systemic immunosuppression including systemic corticosteroids
  • Patients with known hypersensitivity to dexamethasone
  • Patients with severe disease requiring critical attention, deemed unsafe by investigator
  • Patients with a history of ocular inflammation or macular edema
  • Patients with allergy or inability to receive intracameral antibiotic
  • Patients on systemic non-steroidal anti-inflammatory drugs (NSAID) greater than 1,200 mg/day
  • Patients with a corticosteroid implant (e.g., Ozurdex)
  • Patients with corneal pathology that predisposes them to unsatisfactory outcomes

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Briana Parker

Bozeman, Montana, United States, 59718

Actively Recruiting

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

CROSSOVER

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

The PRIME Study: A Randomized, Controlled, Prospective Study | DecenTrialz